Table 3.
Variable | Local invasive cancer HR (95 % CI) | Regional/metastatic invasive HR (95 % CI) |
---|---|---|
Age at diagnosis (years) | 1.0 (0.98–1.03) | 1.01 (1.0–1.1) |
Detection by palpation† (vs. mammography) | 2.1 (1.1–4.0) | 2.4 (0.9–6.6) |
Menopausal Status and p16 | ||
Post- and negative | Reference | |
Post- and positive | 1.7 (0.9–3.0) | |
Pre- and negative | 1.2 (0.2–9.6) | |
Pre- and positive | 5.8 (1.9–17.6) | |
p16/COX-2/ER/ERBB2 | ||
Pos/Pos/Neg/Pos | 5.2 (1.4–19.5) | |
All other groupings | 1.0 (referent) |
Univariately significant variables were included in a backward/forward model selection approach
Palpable mass found by the woman or by her physician upon physical examination